Advertisement
Screener

Protara Therapeutics, Inc. (TARA) Income Tax Expense

2.8 / 5 stars · 68/120 Roast Me

Protara Therapeutics, Inc. Income Tax Expense

Protara Therapeutics, Inc. (TARA) reported Income Tax Expense of $0 for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-10-31.

Discontinued › Expense Statement › Income Tax

us-gaap:IncomeTaxExpenseBenefit · last filed 2019-10-31

  • Protara Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2019-09-30 was $0.00.
  • Protara Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2019-06-30 was $0.00.
  • Protara Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2019-03-31 was $0.00.
  • Protara Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2018-09-30 was $0.00.
  • Protara Therapeutics, Inc. income tax expense (benefit) for fiscal 2014 was -$110.00K, a 219.57% decline from fiscal 2013.
  • Protara Therapeutics, Inc. income tax expense (benefit) for fiscal 2013 was $92.00K.
  • Protara Therapeutics, Inc. income tax expense (benefit) for fiscal 2012 was -$140.00K.
Period endIncome Tax Expense (Benefit) 3 monthIncome Tax Expense (Benefit) 6 monthIncome Tax Expense (Benefit) 9 monthIncome Tax Expense (Benefit) 12 month
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$0.00
derived: sum of 2 quarters · filed 2019-10-31
$0.00
10-Q · filed 2019-10-31
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$0.00
10-Q · filed 2019-08-07
2019-03-31$0.00
10-Q · filed 2019-05-08
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$0.00
derived: sum of 2 quarters · filed 2019-10-31
$0.00
10-Q · filed 2019-10-31
2018-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$0.00
10-Q · filed 2019-08-07
2018-03-31$0.00
10-Q · filed 2019-05-08
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$0.00
derived: sum of 2 quarters · filed 2018-11-07
$0.00
10-Q · filed 2018-11-07
2017-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
$0.00
10-Q · filed 2018-08-07
2017-03-31$0.00
10-Q · filed 2018-05-09
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$0.00
derived: sum of 2 quarters · filed 2017-11-07
$0.00
10-Q · filed 2017-11-07
2016-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07
$0.00
10-Q · filed 2017-08-07
2016-03-31$0.00
10-Q · filed 2017-05-10
2015-09-30$0.00
10-Q · filed 2015-11-12
$0.00
derived: sum of 2 quarters · filed 2015-11-12
$0.00
10-Q · filed 2016-11-07
-$110.00K
derived: sum of 4 quarters · filed 2016-05-09
2015-06-30$0.00
10-Q · filed 2015-08-13
$0.00
10-Q · filed 2016-08-08
-$110.00K
derived: sum of 3 quarters · filed 2016-05-09
-$110.00K
derived: sum of 4 quarters · filed 2016-05-09
2015-03-31$0.00
10-Q · filed 2016-05-09
-$110.00K
derived: sum of 2 quarters · filed 2016-05-09
-$110.00K
derived: sum of 3 quarters · filed 2016-05-09
-$110.00K
derived: sum of 4 quarters · filed 2016-05-09
2014-12-31-$110.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-20
-$110.00K
derived: sum of 2 quarters · filed 2015-11-12
-$110.00K
derived: sum of 3 quarters · filed 2015-11-12
-$110.00K
10-K · filed 2015-03-20
2014-09-30$0.00
10-Q · filed 2015-11-12
$0.00
derived: sum of 2 quarters · filed 2015-11-12
$0.00
10-Q · filed 2015-11-12
$92.00K
derived: sum of 4 quarters · filed 2015-11-12
2014-06-30$0.00
10-Q · filed 2015-08-13
$0.00
10-Q · filed 2015-08-13
$92.00K
derived: sum of 3 quarters · filed 2015-08-13
$92.00K
derived: sum of 4 quarters · filed 2015-08-13
2014-03-31$0.00
10-Q · filed 2015-05-13
$92.00K
derived: sum of 2 quarters · filed 2015-05-13
$92.00K
derived: sum of 3 quarters · filed 2015-05-13
2013-12-31$92.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-20
$92.00K
derived: sum of 2 quarters · filed 2015-03-20
$92.00K
10-K · filed 2015-03-20
2013-09-30$0.00
10-Q · filed 2014-11-25
$0.00
10-Q · filed 2014-11-25
2012-12-31-$140.00K
10-K · filed 2015-03-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Alector, Inc. (ALEC)United States$0.213B-1.90
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90